In a recent study, immunotherapy tablets for dust mite allergy reduced the risk of an attack in individuals with moderate to severe asthma.
New research shows higher levels of antibody against a neuraminidase, a flu surface protein, are better predictors of protection against flu infection and its side effects.
International tobacco control experts are prompting FDA regulators to have a more "open-minded" perspective in regards to regulating vaporized nicotine products, including e-cigarettes.
PremieBreathe, a portable infant respiratory device, is being developed by students at Yale University to help treat premature infants in the developing world.
Scientists have used a novel gene therapy to halt the progression of pulmonary hypertension, a form of high blood pressure in the lung blood vessels that is linked to heart failure.
Blocking a certain signaling molecule can relieve symptoms such as mucus production, swelling, and constriction of the airways in the lungs, a discovery that may potentially improve asthma treatment.
In support of World Asthma Day, May 3, the Forum of International Respiratory Societies (FIRS) is calling for more collaborative action in asthma treatment.
A Yale University study suggests that death in older adults from the influenza virus may primarily be caused by a damaging immune response to the flu and not the virus itself.
The US FDA has approved Bevespi Aerosphere inhalation aerosol indicated for the long-term, maintenance treatment of airflow obstruction in patients with COPD.
Smokers with psychiatric disorders who used the drugs Chantix or Wellbutrin were no more likely to experience serious neuropsychiatric side effects than those who used nicotine patches or placebo.
3M Drug Delivery Systems has developed the 3M Intelligent Control Inhaler, which is described as an intuitive device designed to deliver accurate doses of medication.
ResApp has raised $9.74 million for its new smartphone-based system designed to diagnose respiratory ailments.
New data indicates that COPD patients who also have asthma are at an increased risk for severe exacerbations.
Watercress extract taken multiple times a day was shown to notably inhibit the activation of a tobacco-derived carcinogen in cigarette smokers in a recent study.
An article in Anesthesia & Analgesia presents a review and update for hospital-based providers who may encounter vaccine-preventable diseases (VPDs).
A new therapy targets the body's vascular response to sepsis as opposed to the infection itself or the body's inflammation response and has shown positive results in murine studies.
Yale scientists identified a common genetic network for COPD and pulmonary fibrosis that could inform both future research and drug development.
A new study finds a large number of individual sites within the lungs undergo active disease scarring in pulmonary fibrosis.
Praxair Inc's subsidiary, Praxair Canada Inc, has received approval for the sale of its Noxivent brand of inhaled nitric oxide in Canada.
The new website provides greater insight into Nihon Kohden’s products that help professionals across the healthcare system improve the quality of care while controlling costs.